Cargando…

Antimicrobial Treatment of Staphylococcus aureus in Patients With Cystic Fibrosis

Staphylococcus aureus is a ubiquitous human commensal pathogen. It is commonly isolated in cystic fibrosis (CF) patients and is considered one of the main causes of the recurrent acute pulmonary infections and progressive decline in lung function that characterize this inherited life-threatening mul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Esposito, Susanna, Pennoni, Guido, Mencarini, Valeria, Palladino, Nicola, Peccini, Laura, Principi, Nicola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692479/ https://www.ncbi.nlm.nih.gov/pubmed/31447669 http://dx.doi.org/10.3389/fphar.2019.00849

Ejemplares similares

A Peculiar Case of Pneumonia due to Mycoplasma pneumoniae in a Child with Cystic Fibrosis and Sensibilization to Aspergillus fumigatus
por: Peccini, Laura, et al.
Publicado: (2019)

Advantages and Limitations of Bacteriophages for the Treatment of Bacterial Infections
por: Principi, Nicola, et al.
Publicado: (2019)

Oropharyngeal and nasal Staphylococcus aureus carriage by healthy children
por: Esposito, Susanna, et al.
Publicado: (2014)

Short-term antibiotic therapy for the most common bacterial respiratory infections in infants and children
por: Principi, Nicola, et al.
Publicado: (2023)

Antimicrobial stewardship in paediatrics
por: Principi, Nicola, et al.
Publicado: (2016)

Targeting the Intracellular Environment in Cystic Fibrosis: Restoring Autophagy as a Novel Strategy to Circumvent the CFTR Defect
por: Villella, Valeria Rachela, et al.
Publicado: (2013)

Children with recurrent pneumonia and non-cystic fibrosis bronchiectasis
por: Patria, Maria Francesca, et al.
Publicado: (2016)

Probiotics Administration in Cystic Fibrosis: What Is the Evidence?
por: Esposito, Susanna, et al.
Publicado: (2022)

STAPHYLOCOCCUS AUREUS ENTEROTOXINS IN PEOPLE WITH CYSTIC FIBROSIS (CF)
por: Wen, Hongjie, et al.
Publicado: (2020)

Fusogenic Liposomes Increase the Antimicrobial Activity of Vancomycin Against Staphylococcus aureus Biofilm
por: Scriboni, Andreia Borges, et al.
Publicado: (2019)

Combined proteomic and transcriptomic analysis of the antimicrobial mechanism of tannic acid against Staphylococcus aureus
por: Wang, Jing, et al.
Publicado: (2023)

Methicillin-resistant Staphylococcus aureus eradication in cystic fibrosis patients: A randomized multicenter study
por: Dolce, Daniela, et al.
Publicado: (2019)

The Staphylococcus aureus Transcriptome during Cystic Fibrosis Lung Infection
por: Ibberson, Carolyn B., et al.
Publicado: (2019)

Staphylococcus aureus in cystic fibrosis: problem bug or an innocent bystander?
por: Hurley, Matthew N.
Publicado: (2018)

418: Linezolid-resistant Staphylococcus aureus in patients with cystic fibrosis
por: Pitcher, N., et al.
Publicado: (2021)

Biofilm Formation by Staphylococcus aureus in the Specific Context of Cystic Fibrosis
por: Jean-Pierre, Vincent, et al.
Publicado: (2022)

Cystic fibrosis autoantibody signatures associate with Staphylococcus aureus lung infection or cystic fibrosis-related diabetes
por: Yadav, Ruchi, et al.
Publicado: (2023)

Staphylococcus aureus colonization and risk of surgical site infection in children undergoing clean elective surgery: A cohort study
por: Esposito, Susanna, et al.
Publicado: (2018)

Antimicrobial and anti-inflammatory effects of Eugenia brejoensis essential oil in mice wounds infected by Staphylococcus aureus
por: Diniz, Roseana Muniz, et al.
Publicado: (2022)

Antibiotic Tolerance and Treatment Outcomes in Cystic Fibrosis Methicillin-Resistant Staphylococcus aureus Infections
por: Lu, Kuan-Yi, et al.
Publicado: (2022)

Cystic Fibrosis Sputum Impairs the Ability of Neutrophils to Kill Staphylococcus aureus
por: Fantone, Kayla, et al.
Publicado: (2021)

Parallel Evolution of Linezolid Resistant Staphylococcus aureus in Patients with Cystic Fibrosis
por: Pitcher, Nicholas J., et al.
Publicado: (2023)

Parallel evolution of linezolid-resistant Staphylococcus aureus in patients with cystic fibrosis
por: Pitcher, Nicholas J., et al.
Publicado: (2023)

PDE5 Inhibitors as Potential Tools in the Treatment of Cystic Fibrosis
por: Noel, Sabrina, et al.
Publicado: (2012)

Treatment of Cystic Fibrosis: From Gene- to Cell-Based Therapies
por: Allan, Katelin M., et al.
Publicado: (2021)

Synergistic Effect of Pleuromutilins with Other Antimicrobial Agents against Staphylococcus aureus In Vitro and in an Experimental Galleria mellonella Model
por: Dong, Chun-Liu, et al.
Publicado: (2017)

Non-Antimicrobial Adjuvant Therapy Using Ticagrelor Reduced Biofilm-Related Staphylococcus aureus Prosthetic Joint Infection
por: Pant, Narayan, et al.
Publicado: (2022)

Animal Models in the Pathophysiology of Cystic Fibrosis
por: Semaniakou, Anna, et al.
Publicado: (2019)

The Resolution Approach to Cystic Fibrosis Inflammation
por: Recchiuti, Antonio, et al.
Publicado: (2020)

Enhancing Cystic Fibrosis Immune Regulation
por: van Heeckeren, Anna M., et al.
Publicado: (2021)

Type-4 Phosphodiesterase (PDE4) Blockade Reduces NETosis in Cystic Fibrosis
por: Totani, Licia, et al.
Publicado: (2021)

Molecular Epidemiology of Methicillin-resistant Staphylococcus aureus in Children: Comparison between Cystic Fibrosis and Non-cystic Fibrosis Isolates
por: Mimica, Marcelo Jenne, et al.
Publicado: (2012)

Anti–Methicillin-Resistant Staphylococcus aureus Nanoantibiotics
por: Labruère, Raphaël, et al.
Publicado: (2019)

Molecular Identification of Staphylococcus aureus in Airway Samples from Children with Cystic Fibrosis
por: Johnson, Emily J., et al.
Publicado: (2016)

Emergence and spread of worldwide Staphylococcus aureus clones among cystic fibrosis patients
por: Garbacz, Katarzyna, et al.
Publicado: (2018)

Methicillin‐resistant Staphylococcus aureus in health‐care workers with cystic fibrosis in Sydney
por: Song, Yang, et al.
Publicado: (2018)

Bdellovibrio bacteriovorus directly attacks Pseudomonas aeruginosa and Staphylococcus aureus Cystic fibrosis isolates
por: Iebba, Valerio, et al.
Publicado: (2014)

Editorial: Emerging Therapeutic Approaches for Cystic Fibrosis
por: Lopes-Pacheco, Miquéias, et al.
Publicado: (2019)

CFTR and Ca(2+) Signaling in Cystic Fibrosis
por: Antigny, Fabrice, et al.
Publicado: (2011)

Strategies to circumvent the CFTR defect in cystic fibrosis
por: Becq, Frédéric, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_64di7nnp2ncvkpah4s4959br8b